Statement in German national parliament: close the vaccine gap in Africa

10/6/2024 - News

Today our global health advocate Aliénor Devaliere spoke at the German national parliament’s (Deutscher Bundestag – Verwaltung) subcommittee on Global Health. Wemos, along with Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), was invited to discuss vaccine manufacturing and Gavi’s new financial instrument, the African Vaccine Manufacturing Accelerator (AVMA).

In her statement, Aliénor highlighted that investments should have conditions ensuring that efforts towards regional vaccine production support local, regional and continental health needs and priorities. This is crucial to improving access to vaccines in Africa, by African manufacturers, for African populations.

Watch the recording of the statement (from 39')

Back to the overview

Webinar recording: report on BioNTech Africa

On 12 June, Wemos and partners organized a webinar on the launch of their case study on the BioNTech Africa facility in Rwanda. The recording of the webinar is now available on YouTube. Read more

News

11/6/2024

Report on BioNTech Africa: more needed to achieve sustainable regional production of medicines

The BioNTech mRNA vaccine manufacturing facility in Rwanda contributes to greater access to mRNA vaccines in Africa in the short-term, but it lacks plans and commitments to enhance sovereignty and self-reliance of the continent in access to health products in the long-term. This is the main conclusion from a case study of the BioNTech Africa facility, conducted by four public health NGOs from Africa and Europe, including Wemos. Read more

News

10/6/2024